Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.
about
Micronutrients in Oncological InterventionCircadian rhythm and cartilage extracellular matrix genes in osseointegration: a genome-wide screening of implant failure by vitamin D deficiencyDeformable Nanovesicles Synthesized through an Adaptable Microfluidic Platform for Enhanced Localized Transdermal Drug Delivery.Updates on osteonecrosis of the jawCompromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in miceOvariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible.The impact of vitamin D status on periodontal surgery outcomes.Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature.Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse modelOsteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.A novel model of bisphosphonate-related osteonecrosis of the jaw in ratsEstablishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.Development of animal model for Bisphosphonates-related osteonecrosis of the jaw (BRONJ)Osteomalacia: the missing link in the pathogenesis of bisphosphonate-related osteonecrosis of the jaws?Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white AmericansEquilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosis of the jaw in rats.Bisphosphonates, vitamin D, parathyroid hormone, and osteonecrosis of the jaw. Could there be a missing link?Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat.Associations between Systemic Markers of Bone Turnover or Bone Mineral Density and Anti-Resorptive Agent-Related Osteonecrosis of the Jaw in Patients Treated with Anti-Resorptive Agents.Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcareVitamin D deficiency: the time to ignore it has passed.The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.The impact of bisphosphonates on oral health: lessons from the past and opportunities for the future.A current update on osteonecrosis of the jaw and bisphosphonates.Re-evaluating the role of vitamin D in the periodontium.Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents.Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link?Experimental osteonecrosis: development of a model in rodents administered alendronate.Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model.Plasticity of Myeloid Cells during Oral Barrier Wound Healing and the Development of Bisphosphonate-related Osteonecrosis of the Jaw.Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease.Effects of locally administered tiludronic acid on experimental periodontitis in rats.Serum levels of 25-hydroxyvitamin D are associated with periodontal disease.Craniomaxillofacial Disorders and Solutions in Humans and Animals.Nitrogen-containing bisphosphonate therapy: assessment of the alveolar bone structure in rats - a blind randomized controlled trial.Immunohistochemical expression of caspase-3, caspase-5, caspase-7 and apoptotic protease-activating factor-1 (APAF-1) in the liver and kidney of rats exposed to zoledronic acid (ZOL) and basic fibroblast growth factor (bFGF)
P2860
Q26764839-7A16C492-8F57-4214-AED5-581246F8138FQ28743583-645E9B15-E5DF-45D7-A923-69FEEB8D76A2Q30357070-B8E4FF95-3884-4C2D-AB7C-1BD5D2A0E1CDQ34234108-27A6D440-51C8-4D82-B625-2ACEDA1930F0Q34393622-EB0066B3-A0E5-4E5E-8CE8-1F88AD034390Q34429959-A02374EC-F059-4ED3-AF78-2F1AE33654B4Q34635733-471460C7-6585-4476-8490-57FB504EF8B4Q35206006-150BB7CC-5BE5-4920-9DC3-4ACFCD1C048CQ35555709-7C9B83F4-5771-46F0-A394-2F109B0BFC0DQ35764778-2FB81D16-768A-46AF-84DD-7D94B76F7934Q35837168-0572AC7E-9B3D-41F7-B0AA-BC210D0B6CB1Q35854092-203EDB64-5DBF-4F73-9CC6-C9D4AF9F7911Q35867167-28504857-B3EB-410C-A8A7-FE5F13D83FE0Q35884204-BECE8839-2C61-4015-AD4E-173351847920Q36182848-C55EFE29-F7BC-49EE-9A28-D3591401C292Q36187658-A0682100-896B-4075-B372-C77933D5A043Q36553571-11D97C7A-C67F-43CA-8889-72591E10F466Q36678930-603DDAEF-66BA-441E-968E-26B30D303B2EQ36681335-5F64869C-B6B6-4148-860F-0B15814092C8Q36753894-9718182F-6C7C-4C04-8847-B70E20DFE916Q37170323-60A9F852-88FE-4C11-974E-0DD50D26C3FBQ37460461-9BF63E3C-D469-4FCE-9981-A156C3F59580Q37499899-9D839FE0-5144-420A-AD69-A64557D1F582Q37538266-9260BE13-8B46-4B8A-AE03-3C72E1138933Q37825639-49E7A1BE-EC4D-46BC-80CD-C9A449B40AAEQ37832692-238A4E75-C1C4-44BA-812B-090C31D4E1E7Q37835357-D81627BC-4617-4229-AFCA-505E66572C5CQ37992647-FE3E92EB-3525-41B8-A0E8-06C9460B7DF5Q38164438-D073CD5C-71EA-462D-B345-6610B4EBD3C1Q38184580-2855E3C4-201B-49AB-B694-AB592AFD89D2Q38216355-62758E10-216C-4828-891C-D621B415F60FQ38828299-AD501690-69C7-40E4-B922-A5E470499D19Q39700905-91F08E16-757F-43B1-B775-86130D35F883Q41161756-5B339F8E-DFE7-4168-958E-24F81930DE31Q42202161-7B18C50C-D957-4042-A728-F49CF894B6F5Q44479944-678D64BD-E234-402B-9266-F59659268A5CQ48328923-A454916D-F6B2-4B2A-8761-A839CC40BD95Q52685161-509E1682-A906-46F6-9E1A-B02640F83CD6Q53000213-5A9A37F0-06F1-4383-B6FA-C12E63239F08Q57154970-5CB326D7-BE3E-441C-B554-18051F45BBC5
P2860
Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Increased prevalence of bispho ...... vitamin D deficiency in rats.
@ast
Increased prevalence of bispho ...... vitamin D deficiency in rats.
@en
type
label
Increased prevalence of bispho ...... vitamin D deficiency in rats.
@ast
Increased prevalence of bispho ...... vitamin D deficiency in rats.
@en
prefLabel
Increased prevalence of bispho ...... vitamin D deficiency in rats.
@ast
Increased prevalence of bispho ...... vitamin D deficiency in rats.
@en
P2093
P2860
P921
P356
P1476
Increased prevalence of bispho ...... vitamin D deficiency in rats.
@en
P2093
Akishige Hokugo
Alan L Felsenfeld
Evelyn M Chung
Ichiro Nishimura
James W Sayre
Neal Garrett
Russell Christensen
P2860
P304
P356
10.1002/JBMR.23
P577
2010-06-01T00:00:00Z